Kenneth Atz

14PUBLICATIONS
60CO-AUTHORS
Biologically active moleculesChemical and thermal processes in energy and combustionReaction engineering (excl. nuclear reactions)Biomolecular modelling and designContext learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Mar 20, 2026
Single-position ligand modifications tune CB2R activity by targeting the toggle switch.

Rudolf L Z Ganzoni, Miroslav Kosar, Yongqi Han

|Nov 25, 2025
Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization.

David F Nippa, Kenneth Atz, Yannick Stenzhorn

|Oct 30, 2025
Accelerating compound synthesis in drug discovery: the role of digitalisation and automation.

David F Nippa, Alexander J Boddy, Kenneth Atz

|Jan 27, 2025
Discovery of 1,3,4-Oxadiazin-5-One Derivative CJ1-34 as a Partial ATP Synthase Inhibitor for CNS Applications.

Caitlin V M L Jie, Aro Delparente, Lisa Reichert

|Jan 23, 2025
Simple User-Friendly Reaction Format.

David F Nippa, Alex T Müller, Kenneth Atz

|Jan 17, 2025
Author Correction: Prospective de novo drug design with deep interactome learning.

Kenneth Atz, Leandro Cotos, Clemens Isert

Pageof 3